An activating mutation of AKT2 and human hypoglycemia - PubMed (original) (raw)
. 2011 Oct 28;334(6055):474.
doi: 10.1126/science.1210878. Epub 2011 Oct 6.
B Challis, N Rocha, F Payne, M Minic, A Thompson, A Daly, C Scott, J Harris, B J L Smillie, D B Savage, U Ramaswami, P De Lonlay, S O'Rahilly, I Barroso, R K Semple
Affiliations
- PMID: 21979934
- PMCID: PMC3204221
- DOI: 10.1126/science.1210878
An activating mutation of AKT2 and human hypoglycemia
K Hussain et al. Science. 2011.
Abstract
Pathological fasting hypoglycemia in humans is usually explained by excessive circulating insulin or insulin-like molecules or by inborn errors of metabolism impairing liver glucose production. We studied three unrelated children with unexplained, recurrent, and severe fasting hypoglycemia and asymmetrical growth. All were found to carry the same de novo mutation, p.Glu17Lys, in the serine/threonine kinase AKT2, in two cases as heterozygotes and in one case in mosaic form. In heterologous cells, the mutant AKT2 was constitutively recruited to the plasma membrane, leading to insulin-independent activation of downstream signaling. Thus, systemic metabolic disease can result from constitutive, cell-autonomous activation of signaling pathways normally controlled by insulin.
Figures
Figure 1. Identification of a de novo activating AKT2 mutation
(A) Patient 1 showing increased left leg size, increased left truncal adipose tissue, and surgical feeding tube (B) c.49G>A/p.Glu17Lys mutation in the AKT2 gene seen in either heterozygous or mosaic form. (C) Pedigrees of affected patients, showing de novo occurrence of the mutation in each case. (D) Domain structure of AKT2, showing location of Glu17 in the pleckstrin homology domain and the location of residues phosphorylated by PDK1 and mTORC2 during activation. (E) Plasma membrane recruitment of hemagglutinin-tagged AKT2 p.Glu17Lys but not wild type in serum starved HeLa cells treated with either phosphate buffered saline (PBS) or 100 nmol/l insulin. Nuclei are stained with DAPI. Scale bars = 20μm
Comment in
- Of mice and men: not ExAKTly the same?
Wan M, Birnbaum MJ. Wan M, et al. Cell Metab. 2011 Dec 7;14(6):722-3. doi: 10.1016/j.cmet.2011.11.009. Cell Metab. 2011. PMID: 22152300
Similar articles
- Constitutive Activation of AKT2 in Humans Leads to Hypoglycemia Without Fatty Liver or Metabolic Dyslipidemia.
Minic M, Rocha N, Harris J, Groeneveld MP, Leiter S, Wareham N, Sleigh A, De Lonlay P, Hussain K, O'Rahilly S, Semple RK. Minic M, et al. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2914-2921. doi: 10.1210/jc.2017-00768. J Clin Endocrinol Metab. 2017. PMID: 28541532 Free PMC article. - Activating AKT2 mutation: hypoinsulinemic hypoketotic hypoglycemia.
Arya VB, Flanagan SE, Schober E, Rami-Merhar B, Ellard S, Hussain K. Arya VB, et al. J Clin Endocrinol Metab. 2014 Feb;99(2):391-4. doi: 10.1210/jc.2013-3228. Epub 2013 Nov 27. J Clin Endocrinol Metab. 2014. PMID: 24285683 - Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.
Leiter SM, Parker VER, Welters A, Knox R, Rocha N, Clark G, Payne F, Lotta L, Harris J, Guerrero-Fernández J, González-Casado I, García-Miñaur S, Gordo G, Wareham N, Martínez-Glez V, Allison M, O'Rahilly S, Barroso I, Meissner T, Davies S, Hussain K, Temple K, Barreda-Bonis AC, Kummer S, Semple RK. Leiter SM, et al. Eur J Endocrinol. 2017 Aug;177(2):175-186. doi: 10.1530/EJE-17-0132. Epub 2017 May 31. Eur J Endocrinol. 2017. PMID: 28566443 Free PMC article. - Hypoglycemia due to PI3K/AKT/mTOR signaling pathway defects: two novel cases and review of the literature.
Maines E, Franceschi R, Martinelli D, Soli F, Lepri FR, Piccoli G, Soffiati M. Maines E, et al. Hormones (Athens). 2021 Dec;20(4):623-640. doi: 10.1007/s42000-021-00287-1. Epub 2021 Apr 20. Hormones (Athens). 2021. PMID: 33876391 Review.
Cited by
- The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway.
Şıklar Z, Çetin T, Çakar N, Berberoğlu M. Şıklar Z, et al. J Clin Res Pediatr Endocrinol. 2020 Nov 25;12(4):439-443. doi: 10.4274/jcrpe.galenos.2020.2019.0084. Epub 2020 Mar 11. J Clin Res Pediatr Endocrinol. 2020. PMID: 32157856 Free PMC article. - Somatic mosaicism in the human genome.
Freed D, Stevens EL, Pevsner J. Freed D, et al. Genes (Basel). 2014 Dec 11;5(4):1064-94. doi: 10.3390/genes5041064. Genes (Basel). 2014. PMID: 25513881 Free PMC article. Review. - The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.
Hansel MC, Davila JC, Vosough M, Gramignoli R, Skvorak KJ, Dorko K, Marongiu F, Blake W, Strom SC. Hansel MC, et al. Curr Protoc Toxicol. 2016 Feb 1;67:14.13.1-14.13.27. doi: 10.1002/0471140856.tx1413s67. Curr Protoc Toxicol. 2016. PMID: 26828329 Free PMC article. Review. - Case Report: Functional characterization of a missense variant in INSR associated with hypoketotic hypoglycemia.
Guzman H, Mitteer LM, Chen P, Juliana CA, Boodhansingh K, Lord K, Ganguly A, De Leon DD. Guzman H, et al. Front Pediatr. 2024 Oct 17;12:1493280. doi: 10.3389/fped.2024.1493280. eCollection 2024. Front Pediatr. 2024. PMID: 39483531 Free PMC article. - Somatic mutation, genomic variation, and neurological disease.
Poduri A, Evrony GD, Cai X, Walsh CA. Poduri A, et al. Science. 2013 Jul 5;341(6141):1237758. doi: 10.1126/science.1237758. Science. 2013. PMID: 23828942 Free PMC article. Review.
References
- Cho H, et al. Science. 2001;292:1728. - PubMed
- Hussain K, et al. Horm Res. 2004;61:222. - PubMed
- Materials and methods are available as supporting material in Science Online.
- Pearce LR, Komander D, Alessi DR. Nat Rev Mol Cell Biol. 2010;11:9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- G0600717/MRC_/Medical Research Council/United Kingdom
- 080952/Z/06/Z/WT_/Wellcome Trust/United Kingdom
- 078986/WT_/Wellcome Trust/United Kingdom
- 077016/WT_/Wellcome Trust/United Kingdom
- G0502115/MRC_/Medical Research Council/United Kingdom
- 077016/Z/05/Z/WT_/Wellcome Trust/United Kingdom
- 095515/WT_/Wellcome Trust/United Kingdom
- 091551/Z/10/Z/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- 080952/WT_/Wellcome Trust/United Kingdom
- 091551/WT_/Wellcome Trust/United Kingdom
- 078986/Z/06/Z/WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous